Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size study & Forecast, by Component( Pumps, Oxygenator, Controllers, Cannula, Accessories) by Modality( Veno-Arterial, Veno-Venous and Arterio-Venous), by Patient Type( Neonates, Pediatric,

Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Size study & Forecast, by Component( Pumps, Oxygenator, Controllers, Cannula, Accessories) by Modality( Veno-Arterial, Veno-Venous and Arterio-Venous), by Patient Type( Neonates, Pediatric, Adult), by Application (Respiratory, Cardiac and ECPR) and Regional Analysis, 2022-2029

Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market is valued approximately USD 281.1 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.30% over the forecast period 2022-2029. Extracorporeal membrane oxygenation is used to provide external circulatory support and oxygenate blood outside of the body. Extracorporeal membrane oxygenation machines, which function in the VA (veno-arterial) and VV modes, provide blood oxygenation (veno-venous). Patients undergoing open-heart surgery, respiratory failure, acute respiratory distress syndrome (ARDS), pulmonary embolism, COVID-19, cardiogenic shock, and other respiratory and cardiac problems are candidates for the operation.. The Extracorporeal Membrane Oxygenation (ECMO) Machine market is expanding because of factors such as surging burden of cardiovascular and respiratory diseases and growing adoption of ECMO in lung transplantation procedures. However, high cost of extracorporeal membrane oxygenation (ECMO) Machine may halt market growth.

The International Heart Federation estimates that 18.6 million people worldwide lose their lives to cardiovascular illnesses every year. Another significant aspect boosting demand for these devices is the rising incidence of respiratory disorders such Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Diseases, COVID-19, and Respiratory Failure. A European Respiratory Society publication, for instance, estimates that 4,600 lung transplant operations are carried out worldwide each year. Also, the American Lung Association said that each year in the U.S., roughly 190,000 Individuals receive an ARDS diagnosis. The market for extracorporeal membrane oxygenation machines is expanding as a result of the rising incidence of cardiovascular and respiratory disorders. Along with these, rising technological advancements leading to increased product adoption is creating a lucrative growth to the market.

The key regions considered for the Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to high government support for healthcare, high purchasing power, and increasing prevalence of diseases such as chronic obstructive pulmonary disease in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising healthcare expenditure, rising prevelance of chronic diseases and rising government support to the medical industry.

Major market player included in this report are:
Medtronic plc
Sorin Group
Terumo Cardiovascular Systems Corporation
MAQUET Holding B.V. & Co. KG
Medos Medizintechnik AG
Nipro Medical Corporation
Microport Scientific Corporation
LivaNova PLC
CytoSorbents Corporation
EUROSETS S.R.L

Recent Developments in the Market:
In October 2021, MicroPort Scientific Company acquired Hemovent GmbH, a German Extracorporeal Life Support (ECLS) business, and made investments to expand its German operations.
In July 2021, The Xenios Console, and patient kits for ECMO therapy have been approved by the National Medical Products Administration (NMPA) in China for Xenios AG (Germany).

Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Component, Modality, Patient Type, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Component offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Component:
Pumps
Oxygenator
Controllers
Cannula
Accessories

By Modality:
Veno-Arterial
Veno-Venous
Arterio-Venous
By Patient Type:
Neonates
Pediatric
Adult
By Application:
Respiratory
Cardiac
ECPR
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Medtronic plc
Sorin Group
Terumo Cardiovascular Systems Corporation
MAQUET Holding B.V. & Co. KG
Medos Medizintechnik AG
Nipro Medical Corporation
Microport Scientific Corporation
LivaNova PLC
CytoSorbents Corporation
EUROSETS S.R.L

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.